当前位置:首页 - 行情中心 - 辰欣药业(603367) - 财务分析 - 现金流量表

辰欣药业

(603367)

  

流通市值:72.34亿  总市值:72.58亿
流通股本:4.51亿   总股本:4.53亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金887,306,146.013,755,428,118.992,858,124,582.81,982,973,782.23
收到的税费返还-1,284,716.221,604,245.55325,390.21
收到其他与经营活动有关的现金36,908,871.12105,790,024.2243,473,956.5571,591,510.57
经营活动现金流入的平衡项目0000
经营活动现金流入小计924,215,017.133,862,502,859.432,903,202,784.92,054,890,683.01
购买商品、接受劳务支付的现金233,514,291.551,029,706,603.55714,100,756.8445,951,849.77
支付给职工以及为职工支付的现金105,033,661.47433,323,208.77309,031,492.33208,852,660.09
支付的各项税费129,191,129.6434,317,299.85357,934,285.5265,878,623.76
支付其他与经营活动有关的现金211,444,287.971,513,914,985.661,150,970,463.41918,510,305.08
经营活动现金流出的平衡项目0000
经营活动现金流出小计679,183,370.593,411,262,097.832,532,036,998.041,839,193,438.7
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额245,031,646.54451,240,761.6371,165,786.86215,697,244.31
二、投资活动产生的现金流量:
收回投资收到的现金--21,240.8221,240.82
取得投资收益收到的现金10,844,203.1546,767,354.8638,243,710.4826,160,187.36
处置固定资产、无形资产和其他长期资产收回的现金净额48,000762,331443,136265,000
收到的其他与投资活动有关的现金630,000,0002,396,343,451.772,594,458,278.261,845,717,167.57
投资活动现金流入的平衡项目0000
投资活动现金流入小计640,892,203.152,443,873,137.632,633,166,365.561,872,163,595.75
购建固定资产、无形资产和其他长期资产支付的现金28,324,399.6117,708,793.9823,474,051.7317,924,729.46
投资支付的现金--10,400,0002,770,000
支付其他与投资活动有关的现金834,006,643.842,804,291,430.042,929,494,612.612,129,304,556.63
投资活动现金流出的平衡项目0000
投资活动现金流出小计862,331,043.452,822,000,224.022,963,368,664.342,149,999,286.09
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-221,438,840.3-378,127,086.39-330,202,298.78-277,835,690.34
三、筹资活动产生的现金流量:
吸收投资收到的现金--5,000,0002,000,000
取得借款收到的现金30,000,00054,000,00050,000,00010,000,000
收到其他与筹资活动有关的现金3,103,737.630,978,955.3940,964,600.75479,301.2
筹资活动现金流入平衡项目0000
筹资活动现金流入小计33,103,737.684,978,955.3995,964,600.7512,479,301.2
偿还债务支付的现金-55,500,00050,500,00010,500,000
分配股利、利润或偿付利息支付的现金1,348,244.49159,728,664.69158,067,696.69155,007,337.61
其中:子公司支付给少数股东的股利、利润-3,600,000--
支付其他与筹资活动有关的现金101,767,928.073,550,712.97542,839.66532,979.16
筹资活动现金流出平衡项目0000
筹资活动现金流出小计103,116,172.56218,779,377.66209,110,536.35166,040,316.77
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-70,012,434.96-133,800,422.27-113,145,935.6-153,561,015.57
四、汇率变动对现金及现金等价物的影响70,096.85646,753.56596,207.82594,349.59
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-46,349,531.87-60,039,993.5-71,586,239.7-215,105,112.01
加:期初现金及现金等价物余额983,389,232.24995,682,471.84997,947,754.62995,682,471.84
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额937,039,700.37935,642,478.34926,361,514.92780,577,359.83
补充资料:
净利润-525,426,343.75-266,887,992.07
资产减值准备-2,336,432.75-3,117,728.62
固定资产和投资性房地产折旧-221,416,540.28-87,078,919.64
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-221,416,540.28-87,078,919.64
无形资产摊销-9,329,536.1-4,563,335.67
长期待摊费用摊销-1,957,002.38-374,202.69
处置固定资产、无形资产和其他长期资产的损失--594,288.55-1,351,241.65
固定资产报废损失-775,243.28--
公允价值变动损失-10,374,508.53--26,475,958.44
财务费用-6,753,482.9--16,307,914.06
投资损失--44,117,533.05--15,603,427.69
递延所得税-8,111,959.29-4,456,003.63
其中:递延所得税资产减少-6,891,842.3--5,034,919.48
递延所得税负债增加-1,220,116.99-9,490,923.11
存货的减少--144,307,446.39--207,446,133.07
经营性应收项目的减少--336,444,914.03-289,193,578.71
经营性应付项目的增加-118,506,645.43--200,765,633.23
其他--4,920,350.18--10,713,522.79
现金的期末余额-935,642,478.34-780,577,359.83
减:现金的期初余额-995,682,471.84-995,682,471.84
公告日期2024-04-232024-04-232023-10-272023-08-25
审计意见(境内)标准无保留意见
TOP↑